Header Logo

Connection

Scott Sperling to Parkinson Disease

Back to Details
This is a "connection" page, showing publications Scott Sperling has written about Parkinson Disease.
Scott Sperling
Connection Strength
6.042
Parkinson Disease
  1. Crowley BZ, Patrie J, Sperling SA. Depression differentially affects patient and caregiver perceptions of neuropsychiatric symptoms in Parkinson's disease. Clin Neuropsychol. 2023 08; 37(6):1191-1206.
    View in: PubMed
    Score: 0.722
  2. Sperling SA, Druzgal J, Blair JC, Flanigan JL, Stohlman SL, Barrett MJ. Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson's disease. Clin Neuropsychol. 2023 04; 37(3):676-694.
    View in: PubMed
    Score: 0.707
  3. Stohlman SL, Barrett MJ, Sperling SA. Factor structure of the BDI-II in Parkinson's disease. Neuropsychology. 2021 Jul; 35(5):540-546.
    View in: PubMed
    Score: 0.660
  4. Brown DS, Barrett MJ, Flanigan JL, Sperling SA. Clinical and demographic correlates of apathy in Parkinson's disease. J Neurol. 2019 Feb; 266(2):507-514.
    View in: PubMed
    Score: 0.562
  5. Sperling SA, Shah BB, Barrett MJ, Bond AE, Huss DS, Gonzalez Mejia JA, Elias WJ. Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life. Neurology. 2018 10 02; 91(14):e1275-e1284.
    View in: PubMed
    Score: 0.549
  6. Barrett MJ, Smolkin ME, Flanigan JL, Shah BB, Harrison MB, Sperling SA. Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia. Parkinsonism Relat Disord. 2017 Oct; 43:56-60.
    View in: PubMed
    Score: 0.508
  7. Wyman-Chick KA, Martin PK, Barrett MJ, Manning CA, Sperling SA. Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson Disease. J Geriatr Psychiatry Neurol. 2017 May; 30(3):178-183.
    View in: PubMed
    Score: 0.498
  8. Piccinin CC, Yu JRT, Brooks A, Clark P, Shaffer S, Sokola BS, Lewin K, Whitman JP, Sperling SA, Fernandez HH, Walter BL. Electronic health record tools as a potential resource for improving care among hospitalized people with Parkinson's disease. Parkinsonism Relat Disord. 2023 Nov; 116:105896.
    View in: PubMed
    Score: 0.196
  9. Yu JRT, Sonneborn C, Hogue O, Ghosh D, Brooks A, Liao J, Fernandez HH, Shaffer S, Sperling SA, Walter BL. Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration. Parkinsonism Relat Disord. 2023 08; 113:105491.
    View in: PubMed
    Score: 0.192
  10. Barrett MJ, Murphy JM, Zhang J, Blair JC, Flanigan JL, Nawaz H, Dalrymple WA, Sperling SA, Patrie J, Druzgal TJ. Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease. Parkinsonism Relat Disord. 2021 09; 90:27-32.
    View in: PubMed
    Score: 0.168
  11. Mart?nez-Fern?ndez R, M??ez-Mir? JU, Rodr?guez-Rojas R, Del ?lamo M, Shah BB, Hern?ndez-Fern?ndez F, Pineda-Pardo JA, Monje MHG, Fern?ndez-Rodr?guez B, Sperling SA, Mata-Mar?n D, Guida P, Alonso-Frech F, Obeso I, Gasca-Salas C, Vela-Desojo L, Elias WJ, Obeso JA. Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease. N Engl J Med. 2020 12 24; 383(26):2501-2513.
    View in: PubMed
    Score: 0.161
  12. Dalrymple WA, Huss DS, Blair J, Flanigan JL, Patrie J, Sperling SA, Shah BB, Harrison MB, Druzgal TJ, Barrett MJ. Cholinergic nucleus 4 atrophy and gait impairment in Parkinson's disease. J Neurol. 2021 Jan; 268(1):95-101.
    View in: PubMed
    Score: 0.157
  13. Dalrymple WA, Pusso A, Sperling SA, Flanigan JL, Huss DS, Harrison MB, Elias WJ, Shah BB, Barrett MJ. Comparison of Parkinson's Disease Patients' Characteristics by Indication for Deep Brain Stimulation: Men Are More Likely to Have DBS for Tremor. Tremor Other Hyperkinet Mov (N Y). 2019; 9.
    View in: PubMed
    Score: 0.148
  14. Barrett MJ, Sperling SA, Blair JC, Freeman CS, Flanigan JL, Smolkin ME, Manning CA, Druzgal TJ. Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease. J Neurol Neurosurg Psychiatry. 2019 11; 90(11):1251-1256.
    View in: PubMed
    Score: 0.145
  15. Kuhlman GD, Flanigan JL, Sperling SA, Barrett MJ. Predictors of health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord. 2019 08; 65:86-90.
    View in: PubMed
    Score: 0.144
  16. Barrett MJ, Blair JC, Sperling SA, Smolkin ME, Druzgal TJ. Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease. Neurology. 2018 05 01; 90(18):e1618-e1626.
    View in: PubMed
    Score: 0.133
  17. Wyman-Chick KA, Martin PK, Weintraub D, Sperling SA, Erickson LO, Manning CA, Barrett MJ. Selection of Normative Group Affects Rates of Mild Cognitive Impairment in Parkinson's Disease. Mov Disord. 2018 05; 33(5):839-843.
    View in: PubMed
    Score: 0.132
  18. Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB, Sperling SA, Wang XQ, Gwinn R, Witt J, Ro S, Elias WJ. Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2017 12 01; 74(12):1412-1418.
    View in: PubMed
    Score: 0.130
  19. Groth CL, Pusso A, Sperling SA, Huss DS, Elias WJ, Wooten GF, Barrett MJ. Capgras Syndrome in Advanced Parkinson's Disease. J Neuropsychiatry Clin Neurosci. 2018; 30(2):160-163.
    View in: PubMed
    Score: 0.130
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.